A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader

M Monica C. Rodrigo-Brenni J Jasper C. Komen G Ghaith M. Hamza N Natacha Bohin T Tomas Adomavicius A Angelo Andres S Stefan Blaho U Ulf Börjesson G Gavin W. Collie G Gian Marco De Donatis F Frederik Eisele N Ning Gao (Division of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences) A Andrea Gohlke C Christoph Grebner F Frida Gustafsson A Andreas Hock C Cecilia Kankkonen P Praveen Kumar E Emilyanne Leonard X Xin Li R Ruth Macdonald K Katja Madeyski-Bengtson E Eric Miele P Philip Nevin J Jeroen Overman F Fiona Pachl C Claudio Pathe M Matthew W. D. Perry C Christopher Phillips A Andy Pike I Ian Purvis T Timothy Rasmusson S Sophie Regan L Linda Reilly J Jonathan Rose R R. Ian Storer (Hit Discovery, Discovery Sciences, R&D, AstraZeneca, 1 Francis Crick Ave, Cambridge CB2 0AA, U.K.) J Jingwen Wang X Xiang Zhai I Iacovos N. Michaelides K Kevin Moreau

Article Details

Volume / Issue Vol. 17, Issue 1
Published March 25, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (40)

M

Monica C. Rodrigo-Brenni

J

Jasper C. Komen

G

Ghaith M. Hamza

N

Natacha Bohin

T

Tomas Adomavicius

A

Angelo Andres

S

Stefan Blaho

U

Ulf Börjesson

G

Gavin W. Collie

G

Gian Marco De Donatis

F

Frederik Eisele

N

Ning Gao

Division of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences

A

Andrea Gohlke

C

Christoph Grebner

F

Frida Gustafsson

A

Andreas Hock

C

Cecilia Kankkonen

P

Praveen Kumar

E

Emilyanne Leonard

X

Xin Li

R

Ruth Macdonald

K

Katja Madeyski-Bengtson

E

Eric Miele

P

Philip Nevin

J

Jeroen Overman

F

Fiona Pachl

C

Claudio Pathe

M

Matthew W. D. Perry

C

Christopher Phillips

A

Andy Pike

I

Ian Purvis

T

Timothy Rasmusson

S

Sophie Regan

L

Linda Reilly

J

Jonathan Rose

R

R. Ian Storer

Hit Discovery, Discovery Sciences, R&D, AstraZeneca, 1 Francis Crick Ave, Cambridge CB2 0AA, U.K.

J

Jingwen Wang

X

Xiang Zhai

I

Iacovos N. Michaelides

K

Kevin Moreau